Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2.

作者: Mei Jiang , Xin Shi , Hua Zhu , Wu Wei , Jinyan Li

DOI: 10.12659/MSM.916815

关键词:

摘要: BACKGROUND Medullary thyroid carcinoma (MTC), a rare type of cancer, is big challenge in clinical treatment. However, the pathogenesis MTC remains poorly understand. MicroRNAs (miRNAs) were previously demonstrated to be involved MTC, however, roles majority miRNAs are still undetermined. MATERIAL AND METHODS Two GEO miRNA expression profiles (GSE40807, GSE97070) downloaded, and differentially expressed (DEmiRNAs) GSE40807 GSE97070 analyzed by bioinformatics methods. Expressions detected quantitative real-time polymerase chain reaction; cell proliferation was examined through Cell Counting Kit-8, colony formation vivo tumor growth assays; interaction between mRNA verified dual-luciferase reporter assay; functional analysis target genes performed using Database for Annotation, Visualization Integrated Discovery (DAVID, www.david.ncifcrf.gov) software. RESULTS Ten identified dysregulated both datasets, miR-31-3p showed highest change fold (Log change=-3.460625 Log change=-0.07084374 GSE97070). MiR-31-3p significantly downregulated low poor prognosis relative high (P<0.05). Functionally, inhibited vitro vivo. Functional also that numerous biochemical processes pathways, which Ras signaling pathway selected further study. RASA2, overexpressed negatively regulated miR-31-3p. In addition, we found knockdown RASA2 proliferation. CONCLUSIONS Reduced level might play key role tumorigenesis targeting critical especially pathway.

参考文章(45)
Ruilei Liu, Jie Li, Yuanhui Lai, Yi Liao, Ruiming Liu, Wanshou Qiu, Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1 International Journal of Biological Macromolecules. ,vol. 81, pp. 491- 497 ,(2015) , 10.1016/J.IJBIOMAC.2015.08.016
Marina N. Nikiforova, George C. Tseng, David Steward, Donna Diorio, Yuri E. Nikiforov, MicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility The Journal of Clinical Endocrinology and Metabolism. ,vol. 93, pp. 1600- 1608 ,(2008) , 10.1210/JC.2007-2696
Leike Xie, Paul A. Overbeek, Lixing W. Reneker, Ras signaling is essential for lens cell proliferation and lens growth during development Developmental Biology. ,vol. 298, pp. 403- 414 ,(2006) , 10.1016/J.YDBIO.2006.06.045
Kevin M Haigis, Krystle R Kendall, Yufang Wang, Ann Cheung, Marcia C Haigis, Jonathan N Glickman, Michiko Niwa-Kawakita, Alejandro Sweet-Cordero, Judith Sebolt-Leopold, Kevin M Shannon, Jeffrey Settleman, Marco Giovannini, Tyler Jacks, Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon Nature Genetics. ,vol. 40, pp. 600- 608 ,(2008) , 10.1038/NG.115
Serena Giunti, Alessandro Antonelli, Andrea Amorosi, Libero Santarpia, Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma. International Journal of Endocrinology. ,vol. 2013, pp. 803171- 803171 ,(2013) , 10.1155/2013/803171
Jena Hudson, Eric Duncavage, Anna Tamburrino, Paolo Salerno, Liqiang Xi, Mark Raffeld, Jeffrey Moley, Rebecca D. Chernock, Overexpression of miR-10a and miR-375 and downregulation of YAP1 in medullary thyroid carcinoma. Experimental and Molecular Pathology. ,vol. 95, pp. 62- 67 ,(2013) , 10.1016/J.YEXMP.2013.05.001
Gilles Manceau, Sandrine Imbeaud, Raphaële Thiébaut, François Liébaert, Karine Fontaine, Francis Rousseau, Bérengère Génin, Delphine Le Corre, Audrey Didelot, Marc Vincent, Jean-Baptiste Bachet, Benoist Chibaudel, Olivier Bouché, Bruno Landi, Frédéric Bibeau, Karen Leroy, Frédérique Penault-Llorca, Jean-Luc Van Laethem, Pieter Demetter, Sabine Tejpar, Simona Rossi, Neda Mosakhani, Pia Österlund, Raija Ristamäki, Virinder Sarhadi, Sakari Knuutila, Valérie Boige, Thierry André, Pierre Laurent-Puig, Hsa-miR-31-3p Expression Is Linked to Progression-free Survival in Patients with KRAS Wild-type Metastatic Colorectal Cancer Treated with Anti-EGFR Therapy Clinical Cancer Research. ,vol. 20, pp. 3338- 3347 ,(2014) , 10.1158/1078-0432.CCR-13-2750
Jacques Barbet, Loïc Campion, Françoise Kraeber-Bodéré, Jean-François Chatal, Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma The Journal of Clinical Endocrinology and Metabolism. ,vol. 90, pp. 6077- 6084 ,(2005) , 10.1210/JC.2005-0044
Libero Santarpia, George A Calin, Liana Adam, Lei Ye, Alfredo Fusco, Serena Giunti, Christina Thaller, Laura Paladini, Xinna Zhang, Camilo Jimenez, Francesco Trimarchi, Adel K El-Naggar, Robert F Gagel, A miRNA signature associated with human metastatic medullary thyroid carcinoma Endocrine-related Cancer. ,vol. 20, pp. 809- 823 ,(2013) , 10.1530/ERC-13-0357
Rand Arafeh, Nouar Qutob, Rafi Emmanuel, Alona Keren-Paz, Jason Madore, Abdel Elkahloun, James S Wilmott, Jared J Gartner, Antonella Di Pizio, Sabina Winograd-Katz, Sivasish Sindiri, Ron Rotkopf, Ken Dutton-Regester, Peter Johansson, Antonia L Pritchard, Nicola Waddell, Victoria K Hill, Jimmy C Lin, Yael Hevroni, Steven A Rosenberg, Javed Khan, Shifra Ben-Dor, Masha Y Niv, Igor Ulitsky, Graham J Mann, Richard A Scolyer, Nicholas K Hayward, Yardena Samuels, Recurrent inactivating RASA2 mutations in melanoma Nature Genetics. ,vol. 47, pp. 1408- 1410 ,(2015) , 10.1038/NG.3427